Nuo Therapeutics, Inc.
AURX
$1.24
$0.010.78%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.27% | 47.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.27% | 47.40% | |||
| Cost of Revenue | 0.44% | 155.14% | |||
| Gross Profit | 10.07% | 15.62% | |||
| SG&A Expenses | 8.77% | -2.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.61% | 16.27% | |||
| Operating Income | -7.26% | 17.16% | |||
| Income Before Tax | -7.55% | 17.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.55% | 17.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.55% | 17.21% | |||
| EBIT | -7.26% | 17.16% | |||
| EBITDA | -7.43% | 17.81% | |||
| EPS Basic | -6.19% | 18.71% | |||
| Normalized Basic EPS | -5.63% | 18.39% | |||
| EPS Diluted | -6.19% | 18.71% | |||
| Normalized Diluted EPS | -5.63% | 18.39% | |||
| Average Basic Shares Outstanding | 1.10% | 1.53% | |||
| Average Diluted Shares Outstanding | 1.10% | 1.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||